Advertisement

Topics

Valent de Mexico Company Profile

05:16 EST 19th December 2018 | BioPortfolio

Valent de Mexico is subsidiary of Valent U.S.A., a Sumitomo Chemical Company. With 20 years in the market, Valent de Mexico was the first company within the Mexican Crop Protection Industry to incorporate conventional and biorational proprietary products into their own portfolio. Valent de Mexico is well recognized for working closely with end users and distribution, offering integrated solutions as specialized products with strong field support for Crop Protection and Crop Production needs by the Mexican growers. VdM is headquartered in Guadalajara, Jalisco, Mexico and have Sales and Technical service personnel nationwide. The company web site is www.valent.mx


News Articles [297 Associated News Articles listed on BioPortfolio]

Pfizer Granted FDA Breakthrough Therapy Designation for 20-Valent Pneumococcal Conjugate Vaccine

Pfizer (NYSE:PFE) announced today that its 20-Valent Pneumococcal Conjugate Vaccine (20vPnC) candidate, PF-06482077, received Breakthrough Therapy designation from the US Food and Drug Administration ...

Pfizer Initiates Phase3 Program For 20-Valent Pneumococcal Conjugate Vaccine

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced the initiation of a Phase 3 program for its 20-Valent pneumococcal conjugate vaccine or 20vPnC candidate, PF-06482077, for the prevention of i...

13-Valent Pneumococcal Vaccine Improves Protection Against Acute Otitis Media

The 13-valent pneumococcal conjugate vaccine (PCV13) offers better protection than its predecessor, PCV7, against acute otitis media caused by Streptococcus pneumoniae, according to an...

[Comment] The changing epidemiology of pneumococcal diseases

Substantial decreases in paediatric invasive pneumococcal disease (IPD) have been reported from countries where the 13-valent pneumococcal conjugate vaccine (PCV13) has been introduced for routine use...

[Correspondence] Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach?

Pneumococcal vaccination is the cornerstone in the prevention of invasive pneumococcal disease. The use of the first pneumococcal conjugate vaccine in children, the 7-valent pneumococcal conjugate vac...

FDA Grants Priority Review to Merck’s sBLA for Gardasil 9 for Prevention of HPV-Related Cancers and Diseases

KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for revi...

An opioid epidemic may be looming in Mexico -- and the US may be partly responsible

Though opioid use in Mexico has been low, national and international factors are converging and a threat of increased drug and addiction rates exists. Many of these factors may have originated in the ...

Mexico trade deal impacts biologicals exclusivity

The US announced a new ‘understanding’ on trade with Mexico on 27 August 2018.  The announcement comes as part of efforts to re-negotiate the North American Free Trade Agreement (NAFTA) betwe...

PubMed Articles [416 Associated PubMed Articles listed on BioPortfolio]

Modeling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico.

Pneumococcal diseases caused by Streptococcus pneumoniae represent a significant health and economic burden. Mexico has benefited from the inclusion of the 7-valent (PCV7) and 13-valent pneumococcal c...

Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada.

Pneumococcal conjugate vaccines (PCVs) have been available in Canada since 2001, with 13-valent PCV (PCV13) added to the infant routine immunization program throughout all Canadian provinces by 2011. ...

Knowledge and use of nutrient labelling of industrialized foods and beverages in Mexico.

To keep record of the knowledge and use of information of the different food labels on industrialized products in Mexico.

Outpatient antibiotic use in Dutch infants after 10-valent pneumococcal vaccine introduction: a time-series analysis.

This population-based cohort study assesses the impact of switching from a 7-valent pneumococcal conjugate vaccine (PCV) to a 10-valent PCV on outpatient antibiotic use in Dutch infants, and whether g...

Limited impact of pneumococcal vaccines on invasive pneumococcal disease in Nunavik (Quebec).

In 2002, a mass immunization campaign using the 23-valent pneumococcal polysaccharide vaccine (PPV23) was carried out in Nunavik to control an outbreak caused by a virulent clone of serotype 1 Strepto...

Clinical Trials [261 Associated Clinical Trials listed on BioPortfolio]

7-valent Pneumococcal Conjugated Vaccination

Hypothesis: the efficacy of 2 doses 7-valent PCV is equivalent to 1 dose 7-valent PCV.

Study To Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants.

The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate (13vPnC) vaccine compared to Prevenar (7vPnC), when given concomita...

Study Evaluating a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate (13vPnC) vaccine compared to Prevenar (7vPnC), when given concomita...

Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine Administered to Infants in Korea

The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate vaccine (13vPnC), relative to a 7-valent pneumococcal conjugate va...

Study To Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants.

The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate (13vPnC) vaccine compared to Prevenar (7vPnC), when given concomita...

Companies [239 Associated Companies listed on BioPortfolio]

Valent de Mexico

Valent de Mexico is subsidiary of Valent U.S.A., a Sumitomo Chemical Company. With 20 years in the market, Valent de Mexico was the first company within the Mexican Crop Protectio...

Valent BioSciences Corporation

Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and co...

ValueOptions(R) New Mexico

ValueOptions(R) New Mexico is the statewide entity that manages public funding and delivery of care for behavioral health in New Mexico. The organization is committed to providing behavioral healt...

New Mexico Software, Inc.

New Mexico Software, Inc. develops and provides medical IT services and solutions that enable improved and faster communication within the preventative, comprehensive and c...

University of New Mexico Alumni Association

From the Alumni Center at Hodgin Hall, the Alumni Association and Alumni Relations Office keep the University of New Mexico and its alumni communicating and connected.Everyone who graduates from UNM i...

More Information about "Valent de Mexico" on BioPortfolio

We have published hundreds of Valent de Mexico news stories on BioPortfolio along with dozens of Valent de Mexico Clinical Trials and PubMed Articles about Valent de Mexico for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Valent de Mexico Companies in our database. You can also find out about relevant Valent de Mexico Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record